Rachel Pope, MD, MPH
- Clinical Instructor, CWRU School of Medicine
Rachel Pope, MD, MPH, is an obstetrician/gynecologist in the Department of Urology with an appointment in the Department of Reproductive Biology at University Hospitals Cleveland Medical Center. She is fellowship trained in global women’s health, specifically in childbirth injuries, including obstetric fistula in sub-Saharan Africa. She has additional training in vulvar and vaginal disorders and sexual dysfunction. She has an interest in vaginal reconstruction and provides surgical care for women with vesico-vaginal and recto-vaginal fistulas, postpartum birth injuries, cancer survivors, women with sexual dysfunction, and individuals undergoing gender affirmation surgery. Dr. Pope’s research is primarily focused on obstetric fistula and public health topics, including reproductive health and SARS-CoV-2, and barriers to women’s sexual and reproductive health care.
- Clitoral and Vulvar Reconstruction After Genital Cutting
- Decreased Desire
- Female Sexual Dysfunction
- Female Sexual Health
- Gender Affirmation
- Genitourinary Syndrome of Menopause
- Intimacy Issues
- Lichen Sclerosus
- Pelvic Pain
- Recto-Vaginal Fistula Repair
- Vaginal Atrophy
- Vaginal Dryness
- Vaginal Reconstruction After Cancer
- Vesico-Vaginal Fistula Repair
Patient Experience Reviews
4.8 out of 5
Patient Comments (1)
Reviewed On 8/1/2021
Rachel Pope and her nurse were incredible!
- Obstetrics and Gynecology - American Board of Obstetrics and Gynecology
Fellowship | Global Women’s Health
Global Women’s Health - Baylor College Of Medicine - Texas Medical Center (2015 - 2017)
Residency | Obstetrics and Gynecology
Obstetrics and Gynecology - UH Cleveland Medical Center (2011 - 2015)
Ben-Gurion University Of The Negev (2011)
Case Western Reserve University (2007)
Case Western Reserve University (2006)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Rachel Pope did not disclose any Outside Relationships with Industry.